Abstract |
The response to recombinant hepatitis B vaccine was assessed in 31 seronegative infants (2-26 months old) with protein calorie malnutrition (PCM), compared with 13 seronegative age- and sex-matched healthy infants. Both groups received three 10 micrograms vaccine doses at 0, 1, and 6 months. At month 8, all healthy infants and 87 per cent (27 out of 31) of PCM infants were seroprotected. Thus, hepatitis B vaccination ( Engerix-B, SmithKline Beecham Biologicals) can be used effectively in PCM for mass vaccination in developing communities.
|
Authors | Y el-Gamal, R H Aly, E Hossny, E Afify, D el-Taliawy |
Journal | Journal of tropical pediatrics
(J Trop Pediatr)
Vol. 42
Issue 3
Pg. 144-5
(06 1996)
ISSN: 0142-6338 [Print] England |
PMID | 8699579
(Publication Type: Journal Article)
|
Chemical References |
- Hepatitis B Antibodies
- Hepatitis B Vaccines
|
Topics |
- Child, Preschool
- Developing Countries
- Egypt
- Female
- Hepatitis B
(immunology, prevention & control)
- Hepatitis B Antibodies
(biosynthesis)
- Hepatitis B Vaccines
(administration & dosage, immunology)
- Humans
- Immunization Schedule
- Infant
- Male
- Protein-Energy Malnutrition
(immunology)
- Vaccination
|